Development and evaluation of an inhalation aerosol of nitroglycerin.
D000281:Administration, Intranasal; D000284:Administration, Oral; D000328:Adult; D000335:Aerosol Propellants; D000336:Aerosols; D000704:Analysis of Variance; D001794:Blood Pressure / Q000187:drug effects; D004339:Drug Compounding; D004349:Drug Packaging; D004355:Drug Stability; D004562:Electrocardiography; D006261:Headache / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009060:Mouth Floor; D005996:Nitroglycerin / Q000008:administration & dosage* / Q000032:analysis / Q000494:pharmacology; D010316:Particle Size; D010919:Placebos; D010991:Plethysmography; D011409:Propylene Glycols; D013607:Tablets; D013997:Time Factors
D000335:Aerosol Propellants; D000336:Aerosols; D010919:Placebos; D011409:Propylene Glycols; D013607:Tablets; D005996:Nitroglycerin